Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis

The IMCI is one of WHO/UNICEF's most successful strategies in reducing mortality in children under five years of age [7]. Since it was first conceived in 1997, it has provided over 75 countries with easy-to-use tools for primary care health workers to promptly identify and treat life-threatenin...

Full description

Saved in:
Bibliographic Details
Published in:PLoS neglected tropical diseases 2016-09, Vol.10 (9), p.e0004946-e0004946
Main Authors: Bustinduy, Amaya L, Friedman, Jennifer F, Kjetland, Eyrun Floerecke, Ezeamama, Amara E, Kabatereine, Narcis B, Stothard, J Russell, King, Charles H
Format: Article
Language:English
Subjects:
Age
Biology and Life Sciences
Colleges & universities
Disease
Disease prevention
Dosage and administration
Drug therapy
Funding
Hospitals
Medicine
Medicine and Health Sciences
Mortality
Pediatric pharmacology
Pediatrics
Praziquantel
Primary care
Public health
Schistosomiasis
Tropical diseases
Viewpoints
Workers
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The IMCI is one of WHO/UNICEF's most successful strategies in reducing mortality in children under five years of age [7]. Since it was first conceived in 1997, it has provided over 75 countries with easy-to-use tools for primary care health workers to promptly identify and treat life-threatening conditions such as pneumonia, diarrhea, malaria, measles, and malnutrition. [...]the surplus from MDA programs could be given to health centers to allow year-round continuity of treatment.
ISSN:1935-2735
1935-2727
1935-2735
DOI:10.1371/journal.pntd.0004946